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AbstrACt
Objectives To determine the availability of continuous 
positive airway pressure (CPAP) and to provide an overview 
of its use in neonatal units in government hospitals across 
India.
setting Cross- sectional cluster survey of a nationally 
representative sample of government hospitals from 
across India.
Primary outcomes Availability of CPAP in neonatal units.
secondary outcomes Proportion of hospitals where 
infrastructure and processes to provide CPAP are available. 
Case fatality rates and complication rates of neonates 
treated with CPAP.
results Among 661 of 694 government hospitals with 
neonatal units that provided information on availability of 
CPAP for neonatal care, 68.3% of medical college hospitals 
(MCH) and 36.6% of district hospitals (DH) used CPAP in 
neonates. Assessment of a representative sample of 142 
hospitals (79 MCH and 63 DH) showed that air- oxygen 
blenders were available in 50.7% (95% CI 41.4% to 60.9%) 
and staff trained in the use of CPAP were present in 56.0% 
(45.8% to 65.8%) of hospitals. The nurse to patient ratio 
was 7.3 (6.4 to 8.5) in MCH and 6.6 (5.5 to 8.3) in DH. 
Clinical guidelines were available in 31.0% of hospitals 
(22.2% to 41.4%). Upper oxygen saturation limits of above 
94% were used in 72% (59.8% to 81.6%) of MCH and 
59.3% (44.6% to 72.5%) of DH. Respiratory circuits were 
reused in 53.8% (42.3% to 63.9%) of hospitals. Case fatality 
rate for neonates treated with CPAP was 21.4% (16.6% to 
26.2%); complication rates were 0.7% (0.2% to 1.2%) for 
pneumothorax, 7.4% (0.9% to 13.9%) for retinopathy and 
1.4% (0.7% to 2.1%) for bronchopulmonary dysplasia.
Conclusions CPAP is used in neonatal units across 
government hospitals in India. Neonates may be 
overexposed to oxygen as the means to detect and treat 
consequences of oxygen toxicity are insufficient. Neonates 
may also be exposed to nosocomial infections by reuse of 
disposables. Case fatality rates for neonates receiving CPAP 
are high. Complications might be under- reported. Support 
to infrastructure, training, guidelines implementation and 
staffing are needed to improve CPAP use.
IntrOduCtIOn
An estimated 2.9 million neonates die every 
year worldwide. Most of these deaths are in 
low- income and middle- income countries 
(LMIC) and result from prematurity, intra- 
partum- related conditions and infections.1 
Acute respiratory distress, common to these 
causes of death, is associated with case fatality 
rates as high as 20% in LMIC.2 The most basic 
respiratory support for neonates with acute 
respiratory distress is oxygen, followed by 
non- invasive support such as continuous posi-
tive airway pressure (CPAP), and by mechan-
ical ventilation. Mechanical ventilation 
involves endotracheal intubation, an invasive 
procedure requiring high technical skills. In 
contrast, CPAP can in principle be applied by 
non- specialist healthcare providers.3 It is esti-
mated that the use of oxygen in combination 
with CPAP for the treatment of respiratory 
distress contributed to a 70% increase in the 
survival of preterm babies in high- income 
countries.4 Several studies reported that 
strengths and limitations of this study
 ► Nationwide assessment of the availability and use of 
continuous positive airway pressure (CPAP) in neo-
nates in a representative sample of public hospitals 
in India, through direct hospital site visits.
 ► Our findings apply to government facilities; the avail-
ability and use of CPAP in private hospitals, where a 
large proportion of inpatient care is provided in India, 
may be different.
 ► The standards used to assess the availability of 
essential infrastructures and processes to provide 
CPAP were decided by consensus among the re-
search team, and this carries a degree of subjectivity.
 ► Data about infrastructures and processes were 
based on participants’ reports, and there might have 
been reporting bias.
 ► Data on some important determinants of neonatal 
mortality and morbidity were not collected, which 
precludes firm conclusions on the impact of lack of 
infrastructures and processes on the clinical out-
comes reported.
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CPAP is safe and effective in LMIC and its use in these 
settings is increasing.5–12
However, CPAP use can lead to serious complications 
such as pneumothorax, or nasal trauma.13 14 Moreover, 
when CPAP is used with supplemental oxygen, the 
unregulated use of oxygen may lead to retinopathy of 
prematurity (ROP),15 a major cause of blindness, or bron-
chopulmonary dysplasia (BPD).16
CPAP is easy to initiate, but to be effective, CPAP needs 
to be used continuously for hours or days. This implies 
continuous supplies of electricity and medical gases, 
continuous clinical monitoring for timely detection of 
acute complications and long- term follow- up for chronic 
complications. Consequently, the WHO recommends 
considering the wider context of care prior to intro-
ducing and scaling- up CPAP use in LMIC.17
India accounts for an estimated 779 000 neonatal deaths 
every year.1 The Government of India has launched several 
initiatives to reduce neonatal mortality. These include the 
establishment of Special Newborn Care Units (SNCU) 
which provide level II care including treatment for sepsis, 
jaundice and respiratory distress. SNCU have been imple-
mented in district hospitals (DH), that is, secondary care 
hospitals, and in medical college hospitals (MCH), that is, 
tertiary care hospitals.18 The current national recommen-
dations in terms of respiratory support are to use oxygen 
in DH, and CPAP and mechanical ventilation in MCH.19 
However, CPAP seems to be used in DH.20 The extent of 
CPAP use in neonates at the different levels of care, the 
availability of structures and processes to enable its use, 
and the clinical outcomes of this intervention in India are 
unclear.
The aims of this study were to determine the availability 
of CPAP and to provide an overview of its use in neonatal 
units in government hospitals across India.
MethOds
study design
A cross- sectional cluster survey was conducted among 
neonatal units using CPAP in government hospitals in 
India.
Identification of hospitals using CPAP in neonates
Programme officers responsible for neonatal health in 
all Indian states and union territories were contacted 
to obtain a list of all government MCH and DH with 
SNCU or neonatal intensive care unit (NICU). NICU are 
neonatal units in MCH that existed before the central 
government launched the initiative to implement SNCU 
in DH and MCH. All hospitals with a SNCU/NICU were 
subsequently contacted to enquire whether CPAP was 
used in the neonatal unit.
selection of hospitals
Hospitals were selected for inclusion in the study using 
stratified cluster random sampling. Stratification was by:
1. District performance ranking based on a composite 
health index developed by the Government of India 
to identify districts needing priority investments in 
healthcare.21 High priority districts were defined as the 
bottom 25% of districts for health index scores; non- 
high priority districts were those in the top 75%.
2. Type of neonatal unit—NICU or SNCU. NICU are 
funded and monitored by state governments. SNCU 
are funded and monitored by the central government. 
Because of these differences, we initially considered 
three types of neonatal units: NICU in MCH, SNCU in 
MCH and SNCU in DH.
Prior to sample selection, facilities within the two strata 
determined by district performance were assigned to 
62 clusters, typically either as a state or a subset of the 
districts within a state. Within each of the clusters there 
were between 3 and 10 facilities providing CPAP. These 
clusters were then stratified by type of neonatal unit.
Random sampling (among the 62 clusters) was strat-
ified to ensure that the margin of error in each of the 
three facility- type strata did not exceed 10%, assuming 
the ICC did not exceed 0.1. A list of 42 randomly selected 
clusters was generated using the Runiform function in 
Stata with a sequence for inclusion of hospitals within the 
clusters until the planned sample size (see below) in each 
of the three strata was achieved.
sample size
We initially estimated that the sample sizes of neonatal 
units required to estimate the outcomes of interest with 
95% CI and a margin of error not exceeding 10% would 
be:
 ► 36 NICU in MCH.
 ► 51 SNCU in MCH.
 ► 76 SNCU in DH.
However, during data collection, it became evident that 
NICU and SNCU in MCH were not substantially different 
in organisation (eg, staff deployment, purchasing and 
maintenance of equipment) or provision of neonatal 
healthcare (eg, the same clinical guidelines where avail-
able were used). Therefore, it was decided to combine 
NICU and SNCU into a single stratum (called neonatal 
units in MCH). Treating them as one stratum for 
sampling, the sample size was revised to:
 ► 62 neonatal units in MCH.
 ► 76 neonatal units in DH.
data collection
Data were collected using a structured questionnaire and 
an observational checklist. The questionnaire (available 
as online supplementary data) included 136 questions 
pertaining to availability of structures (infrastructure 
such as equipment, staffing), processes (practice of care) 
and outcomes (clinical outcomes) related to CPAP use, 
following the Donabedian framework for assessing quality 
of healthcare.22 The questionnaire was developed based 
on 11 guidelines from four countries (India, the United 
Kingdom, Australia and Spain) identified through a 
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Figure 1 Hospitals from Indian states and union territories 
included in the assessment.
review of the literature. As there were no international 
standards for CPAP use in neonates, the research team 
(which included neonatologists, paediatricians and 
obstetricians) developed by consensus, a set of 21 stan-
dards for structures and 12 standards for processes. The 
questionnaire allowed collecting data on 17 standards 
for structures and all 12 standards for processes. The 
observational checklist allowed for direct observation of 
four of the remaining structures standards. Data collec-
tion tools were finalised after pilot tests in two hospitals 
in Delhi.
Data were collected during site visits to each hospital 
by paediatric trainees or senior paediatricians who had 
been trained and had participated in pilot testing of data 
collection tools. In each hospital, doctors and nurses who 
were present on the day of the visit answered questions on 
structures that were not observable (eg, the availability of 
a doctor in the neonatal unit 24/7) and processes. Data 
for all neonates treated with CPAP during the 3 months 
preceding the visit were extracted from registers/records 
to assess clinical outcomes. Following this, the neonatal 
unit was visited and assessed using the observational 
checklist to assess availability of observable structures.
All assessments were conducted between May and 
September 2016. Data were collected electronically on 
iPads.
statistical analysis
Descriptive statistics were derived with sampling errors, 
to provide 95% CIs, that account for the variation in 
sizes and values for the clusters sampled. The analysis was 
performed with SPSS 23.0. On average, data for infra-
structure, practice of care and clinical outcomes were 
missing from 0.8%, 8.5% and 44% of hospitals, respec-
tively. Missing data for infrastructure and practice of care 
were considered as ’item not available in the hospital’, 
while missing data for outcomes were not considered in 
the analysis.
To examine whether facilities with better infrastruc-
ture and practice of delivering CPAP have lower case 
fatality rates, we carried out an additional analysis: an 
index was defined which measures the proportion of 18 
infrastructure criteria (all infrastructure criteria, except 
availability of BPD, ROP screening and ROP treatment, 
as these criteria do not have direct impact on immediate 
mortality) and the 12 practices criteria met at each facility. 
A hospital with all criteria met would have an index of 1, 
while a hospital with no criteria met, an index of 0. This 
index was then used as a covariate in logistic regression 
analysis for case fatality rates of newborns treated with 
CPAP. The analysis was weighted to account for the varia-
tion in numbers of cases between facilities. Estimates are 
reported as odd ratios with corresponding 95% CI. The 
additional analysis was performed using Stata V.15.
Patient and public involvement
There was no patient or public involvement.
results
Availability of CPAP
In total, 232 neonatal units in MCH and 462 in DH were 
identified across the states. Information on whether the 
neonatal unit used CPAP could not be obtained for 12.9% 
(30/232) of MCH and 0.6% (3/462) of DH. Overall 138 
of 202 neonatal units at MCH (68.3%) and 168 of 459 
neonatal units at DH (36.6%) used CPAP. Of these, 142 
neonatal units (79 at MCH and 63 at DH) from 33/62 
clusters in 18 states and union territories were assessed 
(figure 1). Twenty- one facilities (8 MCH and 13 DH) from 
6 of the 33 sampled clusters could not be assessed because 
of time constraints and local events (strikes, political 
unrest). Thus, there was a 17% shortfall in the planned 
number of DH facilities (76) but an excess for MCH.
Infrastructure for CPAP
Forty- six MCH (58.2%, 95% CI 44.6% to 70.7%) and 
44 DH (69.8%, 95% CI 54.1% to 82%) used commer-
cial CPAP machines exclusively. These included bubble 
CPAPs, infant flow CPAP systems, mechanical ventilators 
with CPAP mode, or high flow nasal cannula systems. 
Bubble CPAP was the most common system: 87.3% (95% 
CI 80.3% to 92.1%) of all hospitals used this system (see 
online supplementary data for more details on other 
systems). The remaining hospitals used a mixture of 
commercial and indigenous (home- made) devices.
General infrastructure (ie, electricity, medical gases) 
was usually available, although 23.6% of hospitals did not 
have access to technical maintenance for CPAP equip-
ment. None of the hospitals met all the stipulated stan-
dards for infrastructure (table 1).
standard of practice
In general, practice was in line with standards regarding 
general monitoring of a neonate receiving CPAP, except 
for continuous monitoring of respiratory rate and assess-
ment of respiratory distress which were practised in about 
half of all hospitals (table 2). A predefined oxygen satura-
tion range was used in 94.9% of MCH and 92.1% of DH. 
Of these, 72% (95% CI 59.8% to 81.6%) of MCH and 
59.3% (95% CI 44.6% to 72.5%) of DH reported using 
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Table 1 Availability of infrastructure for continuous positive airway pressure (CPAP) at medical college hospitals (MCH, n=79), 
district hospitals (DH, n=63) and for both combined (n=142)
Type of hospital
Total
(n=142)
% (95% CI)
Medical college 
hospitals (n=79) District hospitals (n=63)
% (95% CI) % (95% CI)
Essential infrastructure
General infrastructure
Technical maintenance 77.2 (66.0 to 85.6) 73.0 (57.0 to 84.7) 75.4 (66.2 to 82.6)
Emergency electricity source 93.7 (87.3 to 97.0) 87.3 (68.8 to 95.6) 90.8 (82.3 to 95.5)
Air and oxygen 91.1 (83.0 to 95.6) 88.9 (73.8 to 95.8) 90.1 (82.8 to 94.5)
CPAP- specific infrastructure
Air- oxygen blender for each CPAP device 51.9 (39.7 to 63.8) 49.2 (32.6 to 66.0) 50.7 (41.4 to 60.9)
Range of sizes of nasal interfaces 86.1 (75.6 to 92.5) 87.3 (76.4 to 93.6) 86.6 (79.6 to 91.5)
Guidelines for CPAP use available in the 
immediate area of care
27.8 (19.4 to 38.2) 34.9 (19.5 to 54.3) 31.0 (22.2 to 41.4)
Staffing levels
>1 doctor 24/7 93.7 (85.0 to 97.5) 65.1 (44.8 to 81.1) 81.0 (69.6 to 88.8)
>1 doctor 24/7 trained in CPAP use 63.3 (51.7 to 73.5) 46.8 (29.8 to 64.5) 56.0 (45.8 to 65.8)
>1 doctor technically competent in the 
management of pneumothorax available 24/7
75.9 (64.5 to 84.6) 41.3 (25.7 to 58.8) 60.6 (49.9 to 70.3)
CPAP training plan available 48.1 (34.3 to 62.2) 41.3 (25.7 to 58.8) 45.1 (34.4 to 56.2)
Monitoring
Neonatal pulse oximeters 82.3 (72.2 to 89.2) 93.7 (85.3 to 97.4) 87.3 (80.9 to 91.8)
X- ray 24/7 86.1 (77.4 to 91.8) 54.0 (35.0 to 71.9) 71.8 (60.6 to 80.9)
Transilluminator 17.7 (10.4 to 28.7) 6.3 (1.5 to 23.5) 12.7 (7.4 to 20.9)
Retinopathy of prematurity (ROP) screening 89.9 (77.2 to 95.9) 60.3 (44.0 to 75.6) 76.8 (66.0 to 84.9)
Broncho- pulmonary dysplasia (BPD) screening 62.0 (49.0 to 73.5) 22.2 (12.5 to 36.3) 44.4 (34.8 to 54.4)
Management of complications
Availability of equipment specific to the 
management of neonatal pneumothorax
63.3 (49.8 to 74.9) 20.6 (9.8 to 38.3) 44.4 (34.1 to 55.2)
Other important infrastructure
Availability of caffeine 82.3 (71.6 to 89.5) 58.7 (40.3 to 75.0) 71.8 (60.3 to 81.1)
Availability of surfactant 77.2 (66.6 to 85.2) 49.2 (31.9 to 66.8) 64.8 (53.5 to 74.6)
Availability of humidifiers 55.7 (43.1 to 67.6) 63.5 (48.8 to 76.1) 59.2 (49.6 to 68.0)
Availability of antenatal corticosteroids 93.7 (85.7 to 97.3) 85.7 (75.9 to 91.9) 90.1 (84.6 to 93.8)
Availability of cryotherapy or laser therapy for 
the treatment of ROP
44.3 (30.9 to 58.5) 7.9 (2.9 to 20.0) 28.2 (19.4 to 39.0)
an upper oxygen saturation limit of above 94% (figure 2). 
Processes followed less often were those related to infec-
tion prevention; for example, single use of respiratory 
circuits was practised in only 46.8% (95% CI 34.0% to 
60.1%) of MCH and 47.6% (95% CI 31.5% to 64.2%) of 
DH. Two DH met all the standards for practice.
Clinical outcomes
Overall case fatality rates (CFR) for neonates admitted to 
neonatal units were 13.2% (95% CI 10.7% to 15.7%) in MCH 
and 7.4% (95% CI 5.7% to 9.1%) in DH. The case fatality rate 
among neonates treated with CPAP in MCH and DH were 
19.8% (95% CI 14.6% to 24.9%) and 26.3% (95% CI 15.7% 
to 37.0%), respectively. The most commonly reported compli-
cation in MCH was ROP (8.4%; 95% CI 0.7% to 16.1%). At 
DH level, nasal lesions were the most frequently reported 
complication (5.7%; 95% CI 1.1% to 10.3%) (table 3).
In terms of the relationship between the availability of 
infrastructures, the practice of providing CPAP, and CFR, 
the CFR of hospitals with more infrastructure and practices 
was not significantly different from the CFR of hospitals 
with less infrastructure and practices in place (OR 4.65, 
95% CI 0.46 to 47.2, p=0.30).
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Table 2 Practice of providing continuous positive airway pressure (CPAP) against process standards in medical college 
hospitals, district hospitals and for both combined (n=142)
Type of neonatal unit
Total
(n=142)
% (95% CI)
Medical college 
hospitals (n=79)
% (95% CI)
District hospitals 
(n=63)
% (95% CI)
Essential processes
General clinical monitoring
Continuous monitoring of oxygen saturation 88.6 (79.5 to 94.0) 92.1 (82.9 to 96.5) 90.1 (84.1 to 94.0)
Continuous monitoring of heart rate 89.9 (81.0 to 94.9) 92.1 (81.5 to 96.8) 90.8 (84.7 to 94.7)
Continuous monitoring of respiratory rate 60.8 (45.2 to 74.4) 50.8 (37.4 to 64.1) 56.3 (45.8 to 66.3)
Regular assessment of respiratory distress 40.5 (30.1 to 51.8) 49.2 (30.8 to 67.8) 44.4 (34.3 to 54.9)
CPAP
Use of a predefined initial pressure level 86.1 (78.4 to 91.3) 85.7 (71.6 to 93.5) 85.9 (78.9 to 90.9)
Use of a predefined oxygen saturation range 94.9 (88.3 to 97.9) 92.1 (77.7 to 97.5) 93.7 (87.1 to 97.0)
Verification of air and oxygen temperature 43.0 (30.8 to 56.1) 57.1 (34.2 to 77.3) 49.3 (37.1 to 61.6)
Monitoring of nasal condition 75.9 (62.8 to 85.5) 79.4 (59.4 to 91.0) 77.5 (66.7 to 85.5)
Use of a standardised CPAP weaning process 50.6 (38.4 to 62.8) 61.9 (40.6 to 79.4) 55.6 (44.2 to 66.5)
Infection prevention
Respiratory circuit replaced after 1 week of use 38.0 (27.3 to 50.0) 47.6 (28.2 to 67.8) 42.3 (31.5 to 53.9)
Single use of respiratory circuits 46.8 (34.0 to 60.1) 47.6 (31.5 to 64.2) 47.2 (36.9 to 57.7)
Single use of nasal interface 41.8 (31.4 to 52.9) 47.6 (30.4 to 65.4) 44.4 (34.7 to 54.5)
Figure 2 Upper oxygen saturation limits used.
dIsCussIOn
Two thirds of MCH and one third of DH use CPAP in 
neonates. No hospital met all 21 infrastructure stan-
dards, but two DH met all 12 standards for practice. A 
third of hospitals use home- made devices. Although 
general infrastructure (eg, electricity, medical gases 
and so on) is usually available, only half of all hospitals 
have air- oxygen blenders for every CPAP machine. Basic 
monitoring equipment is generally available. However, 
diagnostic equipment to identify complications of CPAP 
and/or to manage these is limited, especially at DH level. 
More than half of the hospitals reuse respiratory circuits 
or nasal interfaces. Most hospitals use predefined initial 
pressure levels and oxygen saturation ranges, but 72.0% 
of MCH and 59.3% of DH use upper oxygen saturation 
limits above 94%. On average, one nurse provides care 
for seven neonates. Mortality rate for babies on CPAP is 
21.4%. Pneumothorax is reported in <1%, and ROP and 
BPD are reported in 7.4% and 1.4%, respectively.
Our study identified several areas for improvement.
Not all hospitals follow the national recommendation 
that CPAP should be used only in MCH and not in DH.
Not all the infrastructure, manpower and skills needed 
to implement CPAP safely are in place. Some hospi-
tals use home- made devices. Home- made devices are 
more likely to lack an air- oxygen blender for titration of 
oxygen; this increases the risk of oxygen toxicity. In line 
with our findings, a survey by Sundaram and colleagues 
found that only a third of neonatal units in India were 
equipped with air- oxygen blenders.23 Moreover, respira-
tory circuits and nasal interfaces are frequently reused, 
which can expose neonates to nosocomial infections. 
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Circuits and interfaces cannot be autoclaved. Hence, in 
India, they are usually disinfected with activated glutaral-
dehyde solutions. Arai and colleagues in Brazil found that 
anaesthesia circuits were still colonised with pathogens in 
39.3% of circuits after disinfection with activated glutaral-
dehyde solutions.24 Studies from England and the Neth-
erlands have reported episodes of infection outbreaks in 
neonatal and paediatric intensive care units associated 
with reutilisation of respiratory consumables that were 
disinfected but not sterilised.25 26 In terms of staffing, a 
nurse:patient ratio of 1:7 is problematic. It is less than the 
Indian standard of 1:4 for SNCUs,19 27 and insufficient 
for units providing CPAP. In high- income countries, the 
nurse:patient ratio for advanced care is 1:228 to ensure 
continuous clinical monitoring. Insufficient staffing has 
already been reported in the India Newborn Action Plan 
as a barrier to ensuring quality neonatal care.29 In terms 
of skills, the finding that most nurses report using upper 
oxygen saturation limits above 94% is a concern. The 
range to be used in neonates is subject to debate,30 but 
an upper oxygen saturation limit in preterm neonates of 
below 94% is recommended both internationally31 and 
nationally.19 The combination of the lack of air- oxygen 
blenders, the high number of patients monitored per 
nurse and the use of high upper oxygen saturation limits 
may expose neonates to excessive oxygen. ROP was 
indeed the most common complication reported in MCH 
and is a major health issue in India.32–37
The case fatality rate for neonates treated with CPAP in 
this study is in line with reports from India,9 38–43 Iran11 
and South Africa,8 44–46 but other countries, such as Fiji,6 
Latin American countries7 47 48 and high- income coun-
tries13 have reported lower mortality rates. The reported 
rate of pneumothorax in this study is similar to other 
studies from India9 38–40 42 and South Africa,44 but lower 
than in Latin America7 47 and Iran.12 The rate of ROP 
was lower than in other reports from India,31 49 50 Latin 
America47 and Iran.12
The higher rate of mortality in neonates treated with 
CPAP in India may be a consequence of the lack of 
infrastructure and the shortfalls in the practices of care 
presented above, while the lower rates of complications 
could be linked to the lack of equipment to identify them. 
However, in our study, the CFR of neonates who received 
CPAP in better equipped hospitals was not significantly 
different to the CFR of less equipped hospitals.
strengths and limitations
To the best of our knowledge, this is the first nation- wide 
assessment of the availability and use of CPAP in a repre-
sentative sample of public hospitals in India. All units 
were assessed through site- visits. Our results should be 
interpreted considering some limitations. Our findings 
only apply to government facilities; the availability and 
use of CPAP in private hospitals, where a large proportion 
of inpatient care is provided in India, may be different. 
The selection of standards for CPAP use presented in 
this paper was decided by consensus and carries a degree 
of subjectivity. Data about infrastructure and practice of 
providing CPAP were based on participants’ reports, and 
there might have been reporting bias. Clinical outcome 
data were obtained from existing records with some vari-
ability in the availability and quality of these. Finally, we did 
not collect data on important determinants of neonatal 
mortality and morbidity, such as gestational age, the 
severity of disease, nor on whether neonates had received 
surfactant or antenatal corticosteroids, which preclude 
making firm conclusions on the impact of shortfalls in 
infrastructure and practice of care on clinical outcomes.
Implications for practice and further research
While confirming and supporting the strong commitment 
of the Indian Government and healthcare providers to 
use an intervention that contributes to improved survival, 
it is important to take a relook at the current use of CPAP 
in neonatal units of public hospitals, the current national 
guidelines,19 and the implications for scalability.
More MCH should use CPAP, and the recommenda-
tion of using CPAP should be expanded to DH as well. 
The current preference of a commercial bubble system 
should be supported, as this type of CPAP system is more 
likely to have in- built mechanisms to control pressure, 
air- oxygen mix, temperature and humidity of medical 
gases, and is less invasive than CPAP provided by mechan-
ical ventilators. Neonatal units should have enough 
single- use consumables. Staff working in neonatal units 
should comply with recommendations when providing 
oxygen. More nurses should be made available to provide 
neonatal care, and further discussion and guidance are 
required to establish what the minimum nurse/patient 
ratio should be in the context of LMIC settings.
Ensuring all the above should improve the effective-
ness of CPAP use. However, additional data such as the 
case mix of patients in terms of gestational age, severity 
of disease and comorbidities, as well as the use of surfac-
tant and antenatal corticosteroids should be collected to 
better identify the determinants of clinical outcomes of 
CPAP use in India. Moreover, longitudinal studies, inter-
rupted time studies and pragmatic randomised controlled 
trials are needed to assess the effectiveness of CPAP in 
improving neonatal clinical outcomes in the Indian 
context. Finally, international standards for CPAP use in 
neonates should be developed to guide the implementa-
tion, monitoring and evaluation of this intervention.
COnClusIOns
India is embracing the use of CPAP for neonatal care. 
While electricity, medical gases and basic monitoring 
equipment are widely available, further support is needed 
to ensure availability of trained staff, equipment to provide 
oxygen safely and sufficient quantities of disposables to 
avoid reuse. Neonates may be overexposed to oxygen, 
while the means to detect and treat the consequences 
of oxygen toxicity are insufficient. Neonates may also be 
exposed to nosocomial infections because of the reuse 
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of disposables. Case fatality rates for neonates receiving 
CPAP are higher than in other countries, and compli-
cations might be under- reported. Additional studies are 
needed to identify the determinants of clinical outcomes 
when CPAP is used in neonates and to assess the effective-
ness of this intervention in India.
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